![]() |
Faslodex® (Fulvestrant) Injection 500-mg Pack Now Available For The Treatment Of Meta
AstraZeneca (NYSE: AZN) has announced that FASLODEX 500mg packs are now available for physicians to order. FASLODEX 500 mg is approved for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy...
More... |
| All times are GMT -7. The time now is 09:30 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021